Oral Mucositis Treatment Market Report 2026

Oral Mucositis Treatment Market Overview

• Oral Mucositis Treatment market size has reached to $2.14 billion in 2025 • Expected to grow to $3.44 billion in 2030 at a compound annual growth rate (CAGR) of 9.9% • Growth Driver: Surge In Chemotherapy Fueling The Growth Of The Market Due To Enhanced Treatment Efficacy And Patient Comfort • Market Trend: Innovative Treatments Elevate Comfort And Recovery For Cancer Patients • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oral Mucositis Treatment Market?

Oral mucositis treatment refers to therapies aimed at preventing or managing inflammation and ulceration of the mucous membranes in the mouth, commonly caused by chemotherapy or radiation. This treatment reduces discomfort, prevents infections, supports oral healing, and improves the quality of life for cancer patients undergoing aggressive therapies. The main types of oral mucositis treatment are pharmaceutical drugs, laser therapy, cryotherapy, oral rinses and mouthwashes, other treatment types. Pharmaceutical drugs are substances used to diagnose, treat, or prevent diseases by affecting the body's functions or processes. This can be administered through various routes, including oral, intravenous, subcutaneous, topical and other routes of administration. They indicated for specific causes such as chemotherapy induced oral mucositis, radiotherapy induced oral mucositis and other indications. This can be distributed through various channels, including online pharmacies, retail pharmacies, hospital pharmacies and direct sales. These medications are used by a wide range of end-users, such as hospitals, homecare settings, ambulatory surgical centers and long term care facilities.

What Is The Oral Mucositis Treatment Market Growth Forecast?

The oral mucositis treatment market size is expected to see strong growth in the next few years. It will grow to $3.44 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to growth in cancer treatment volumes, increasing adoption of laser therapy, rising focus on supportive oncology care, advancements in mucosal healing agents, expansion of outpatient cancer care. Major trends in the forecast period include increasing use of laser therapy for oral mucositis, growing adoption of preventive oral care protocols, rising demand for topical and supportive therapies, expansion of home-based oral mucositis care, increasing focus on improving cancer patient quality of life.

Global Oral Mucositis Treatment Market Segmentation

1) By Treatment Type: Pharmaceutical Drugs, Laser Therapy, Cryotherapy, Oral Rinses And Mouthwashes, Other Treatment Types 2) By Route Of Administration: Oral, Intravenous, Subcutaneous, Topical, Other Routes Of Administration 3) By Indication: Chemotherapy-induced Oral Mucositis, Radiotherapy-induced Oral Mucositis, Other Indications 4) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Direct Sales 5) By End-User: Hospitals, Homecare Settings, Ambulatory Surgical Centers, Long-term Care Facilities Subsegments: 1) By Pharmaceutical Drugs: Prescription Drugs, Over-the-counter (OTC) Drugs, Biologics, Small Molecule Drugs 2) By Laser Therapy: Low-Level Laser Therapy (LLLT), High-Level Laser Therapy (HLLT) 3) By Cryotherapy: Ice Chips, Cryotherapy Devices 4) By Oral Rinses and Mouthwashes: Antiseptic Rinses, Antifungal Rinses, Antiviral Rinses, Natural Or Herbal Rinses 5) By Other Treatment Types: Nutritional Supplements, Topical Gels and Ointments, Acupuncture

What Is The Driver Of The Oral Mucositis Treatment Market?

The increasing use of chemotherapy is expected to propel the growth of the oral mucositis treatment market going forward. Chemotherapy is a medical treatment that uses powerful chemicals to kill or inhibit the growth of cancer cells. The rise in the use of chemotherapy is driven by its effectiveness in targeting cancer cells, offering patients a higher chance of remission and improved survival rates. Oral mucositis treatment helps relieve pain, promote healing, and prevent complications caused by chemotherapy, improving patient comfort during treatment. For instance, in February 2025, according to University College London, a UK-based multidisciplinary public research university, fewer lung cancer patients in the UK (27.7%) were treated with chemotherapy compared to Canada (35.0%), Norway (45.3%) and Australia (41.4%). Therefore, the increasing use of chemotherapy is driving the growth of the oral mucositis treatment industry.

Key Players In The Global Oral Mucositis Treatment Market

Major companies operating in the oral mucositis treatment market are Sanofi S.A., Alliance Pharma plc, Galera Therapeutics Inc., Soligenix Inc., Innovation Pharmaceuticals Inc., EUSA Pharma, Norgine B.V., Aspen Pharmacare Holdings Limited, Enzychem Lifesciences Corporation, EpicentRx Inc., Monopar Therapeutics Inc., Oragenics Inc., Soleva Pharma LLC, Colgate-Palmolive Company, Sunstar Group, Camurus AB, Swedish Orphan Biovitrum AB (Sobi), Jaguar Health Inc., CANbridge Pharmaceuticals Inc., Amgen Inc.

Global Oral Mucositis Treatment Market Trends and Insights

Major companies operating in the oral mucositis treatment market are focusing on developing advanced quick pain relief products to improve patient comfort, enhance treatment adherence, and support better recovery outcomes. Quick pain relief products refer to the ability of a treatment to rapidly reduce pain and maintain relief over time without causing a sharp, burning, or irritating sensation when applied. For instance, in October 2024, Jaguar Health, a US-based company, launched Gelclair, an FDA-approved oral mucositis prescription product for the management and relief of oral mucositis pain. This innovative oral mucositis treatment features a protective gel action and soothing application, helping relieve pain and support oral function in cancer patients. Gelclair is highly effective, providing rapid pain relief and mucosal protection, making it an ideal treatment for oral mucositis in cancer patients by enhancing comfort and supporting oral function during therapy.

What Are Latest Mergers And Acquisitions In The Oral Mucositis Treatment Market?

In March 2023, EVERSANA, a US-based full-service commercialization partner for life sciences companies, partnered with ChemoMouthpiece LLC to support the U.S. launch and commercialization of the Chemo Mouthpiece, an intra-oral cooling medical device designed to help cancer patients manage and treat oral mucositis. Through this collaboration, EVERSANA aims to leverage its market access, regulatory, analytics, pricing, and distribution capabilities to accelerate patient access, streamline commercial rollout, and maximize market adoption of the device in the oncology supportive care segment. ChemoMouthpiece LLC is a US-based medical device company specializing in intra-oral cryotherapy solutions for chemotherapy-induced oral mucositis.

Regional Insights

North America was the largest region in the oral mucositis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oral Mucositis Treatment Market?

The oral mucositis treatment market consists of revenues earned by entities by providing services such as pain management, and antimicrobial treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The oral mucositis treatment market also includes sales of topical anesthetics, and anti-inflammatory agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oral Mucositis Treatment Market Report 2026?

The oral mucositis treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oral mucositis treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.